GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (OTCPK:EDTXF) » Definitions » Cyclically Adjusted Price-to-FCF

Spectral Medical (Spectral Medical) Cyclically Adjusted Price-to-FCF : (As of Apr. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Spectral Medical Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Spectral Medical Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Spectral Medical's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical Cyclically Adjusted Price-to-FCF Chart

Spectral Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Spectral Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Spectral Medical's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Spectral Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spectral Medical's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spectral Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Spectral Medical's Cyclically Adjusted Price-to-FCF falls into.



Spectral Medical Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Spectral Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Spectral Medical's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.004/125.4675*125.4675
=-0.004

Current CPI (Dec. 2023) = 125.4675.

Spectral Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.023 98.604 -0.029
201406 -0.016 99.473 -0.020
201409 -0.014 99.394 -0.018
201412 -0.008 98.367 -0.010
201503 -0.013 99.789 -0.016
201506 -0.010 100.500 -0.012
201509 -0.009 100.421 -0.011
201512 -0.008 99.947 -0.010
201603 -0.012 101.054 -0.015
201606 -0.011 102.002 -0.014
201609 -0.012 101.765 -0.015
201612 -0.008 101.449 -0.010
201703 -0.005 102.634 -0.006
201706 -0.003 103.029 -0.004
201709 -0.003 103.345 -0.004
201712 -0.003 103.345 -0.004
201803 -0.002 105.004 -0.002
201806 -0.003 105.557 -0.004
201809 -0.002 105.636 -0.002
201812 -0.001 105.399 -0.001
201903 0.001 106.979 0.001
201906 -0.003 107.690 -0.003
201909 -0.003 107.611 -0.003
201912 -0.005 107.769 -0.006
202003 0.016 107.927 0.019
202006 -0.006 108.401 -0.007
202009 -0.007 108.164 -0.008
202012 -0.005 108.559 -0.006
202103 -0.007 110.298 -0.008
202106 -0.009 111.720 -0.010
202109 -0.007 112.905 -0.008
202112 -0.006 113.774 -0.007
202203 -0.007 117.646 -0.007
202206 -0.009 120.806 -0.009
202209 -0.006 120.648 -0.006
202212 -0.006 120.964 -0.006
202303 -0.009 122.702 -0.009
202306 -0.006 124.203 -0.006
202309 -0.009 125.230 -0.009
202312 -0.004 125.468 -0.004

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Spectral Medical  (OTCPK:EDTXF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Spectral Medical Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Spectral Medical's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Spectral Medical (Spectral Medical) Business Description

Traded in Other Exchanges
Address
135 - 2 The West Mall, Finance, Toronto, ON, CAN, M9C 1C2
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The company has one reporting segment Spectral Medical Inc. The Dialco Medical Inc. operations were considered discontinued by the company.